Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cullinan Therapeutics Inc (NQ: CGEM ) 16.71 -0.20 (-1.18%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cullinan Therapeutics Inc < Previous 1 2 3 4 Next > Cullinan Oncology to Participate in Cowen’s 43rd Annual Health Care Conference February 27, 2023 From Cullinan Oncology, Inc. Via GlobeNewswire Week In Review: China Biopharmas Announce Three Out-Licensing Deals Totaling $2 Billion February 18, 2023 Jiangsu Hengrui Pharma out-licensed US rights for a novel small molecule EZH2 inhibitor in a $706 million agreement with Treeline Biosciences of Connecticut. Hengrui will receive an upfront payment of... Via Talk Markets Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed February 13, 2023 From Cullinan Oncology, Inc. Via GlobeNewswire 5 Value Stocks In The Healthcare Sector January 09, 2023 Via Benzinga Insiders Buy Around $15M Of 2 Stocks June 06, 2022 Although the Dow Jones dropped by around 350 points on Friday, there were a few notable insider trades. Via Benzinga Short Volatility Alert: Cullinan Oncology May 17, 2022 On Monday, shares of Cullinan Oncology, Inc. (NASDAQ: CGEM) experienced volatile short activity. After the activity, the stock price went up at 2.45% to $10.88. The overall... Via Benzinga Cullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and the SVB Securities Global Biopharma Conference February 02, 2023 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 01, 2023 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-978, a Novel T-Cell Engager for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma January 24, 2023 From Cullinan Oncology, Inc. Via GlobeNewswire Why Are Cullinan Oncology Shares Rising Today? May 12, 2022 Taiho Pharmaceutical Co Ltd will co-develop and co-commercialize Cullinan Oncology Inc (NASDAQ: CGEM) lead program, CLN-081/TAS6417. Via Benzinga Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 03, 2023 From Cullinan Oncology, Inc. Via GlobeNewswire 5 Value Stocks To Watch In The Healthcare Sector January 02, 2023 Via Benzinga Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 02, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Lead Cancer Program Shows Confirmed ORR Of 41% In Lung Cancer Setting March 29, 2022 Cullinan Oncology Inc (NASDAQ: CGEM) Via Benzinga Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results November 14, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors November 02, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 01, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology to Participate in Upcoming Investor Conferences November 01, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Significantly Increases Ownership Stake in its MICA Subsidiary which Holds Worldwide Rights to Clinical-Stage Novel Monoclonal Antibody CLN-619 October 25, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 03, 2022 From Cullinan Oncology, Inc. Via GlobeNewswire A Look Into Healthcare Sector Value Stocks October 03, 2022 The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 17, 2022 Via Benzinga 90 Biggest Movers From Yesterday May 13, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... Via Benzinga Mid-Afternoon Market Update: Nasdaq Down 200 Points; Dutch Bros Shares Plunge May 12, 2022 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 12, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 12, 2022 Via Benzinga Executives Buy Around $15M Of 4 Stocks April 06, 2022 Although U.S. stocks closed sharply lower on Tuesday, there were a few notable insider trades. Via Benzinga The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia March 29, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 58 Stocks Moving In Thursday's Mid-Day Session May 12, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. Via Benzinga Stocks That Hit 52-Week Lows On Friday April 01, 2022 On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.